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INTRODUCTION
Otitis media with effusion (OME) is common in the pediatric
population. More than 80% of all children will have experienced
OME by the age of 4. In many published studies, the peak inci-
dence of otitis appears to be in the 6- to 36-month age group,
whereas the median age for placement of the ventilation tube
(VT) is about 18 months (1). For recurrent OME, it may be nec-
essary to insert a VT that provides long-term ventilation of the
middle ear to prevent the development of tympanic membrane
retraction, ossicular erosion or formation of a retraction pocket. 
Many factors have been suggested that may affect the VT
function and extrusion. The reported factors include a previous
history of VT insertion (1) the status of the tympanic membrane
(2), the location of the myringotomy incision (3), the side of the
VT insertion and a repeated episode of otorrhea (4), looseness of
the VT at the time of insertion and the shape of the VT (5), and
there are some discrepancies among the reports. There is limited
information on the relationship between the characteristics of
middle ear effusion and the VT extrusion time. The objective of
this study was to determine the various factors that affect the
VT extrusion rate, including the nature of the middle ear effu-
sion.
Objectives. The objective of this study was to determine the various factors that affect the extrusion rate of ventilation
tubes (VTs), including the nature of the middle ear effusion.
Methods. A retrospective chart review of 82 pediatric patients (177 ears) who received VT insertion surgery under gener-
al anesthesia was carried out to evaluate the relationship between various factors and the VT extrusion rate. The
factors we analyzed included age, gender, the adenoid size, the amount and content of the middle ear effusion after
myringotomy, bleeding events, associated adenoidectomy and the findings of the tympanic membrane status, the
tympanometry and the audiometry of the air bone gap.
Results. The mean extrusion time was 254 days (range, 11 to 809 days). The patients with no history of previous VT inser-
tion had a longer extrusion time (mean, 279 days) than did the patients who had undergone previous VT insertion
(mean, 203 days). The patients with serous effusion had the shortest extrusion time (mean, 190 days) as compared to
those patients with glue (273 days) and pus (295 days) effusions. Other factors had no statistical significant relation-
ship with the extrusion time.
Conclusion. The mean VT extrusion time was 254 days. The VT extrusion time was significantly related to the charac-
teristics of the middle ear effusion and a history of previous VT insertion. Thus, the nature of middle ear effusion
can provide a clinical clue to predict the VT extrusion time.
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MATERIALS AND METHODS
A retrospective chart review was carried out for the pediatric
patients who received VT insertion surgery at our department
from July 2001 to April 2008. We excluded those adult cases,
those with use of local anesthesia, those with infection of the
VT and those with combined craniofacial anomaly. The medical
charts of 82 patients (177 times of insertions) who had under-
gone their operation under general anesthesia and who could
be followed up until the VT had extruded after surgery were
retrospectively reviewed. For all the patients, a myringotomy
with insertion of a VT (Paparella type I, Medtronic Xomed,
Jacksonville, FL, USA) was performed under general anesthe-
sia. The patients were evaluated one week and one month after
the operation, and thereafter every three months at the outpa-
tient clinic.
The date of extrusion was calculated as the midpoint between
the last date when the VT was seen to be in situ and the first
date when the VT was seen to be extruded. We evaluated the
age, gender, associated adenoidectomy, the adenoid size, the
amount and content of the middle ear effusion after myringoto-
my, bleeding events and the findings of the tympanic mem-
brane status, the tympanometry and the audiometry of the air
bone gap. The patients were divided into two groups based on
the age of 7. An independent t-test was used to compare the
extrusion time between the patients who were younger (<7 yr)
and those who were older (≥7 yr), the males and females, those
with/without a previous history of VT insertion and those who
had/had not undergone adenoidectomy. Before the operation,
tympanometry was performed and the audiometry was evalu-
ated. The threshold of hearing was calculated by the 4 division
method, and then the air bone gap (dB) was calculated. The VT
extrusion time was compared for the patients with preoperative
tympanometry B and C and whose air bone gap on audiometry
before the operation was 20 dB or smaller vs. those patients
with preoperative tympanometry B and C and whose air bone
gap on audiometry before the operation larger than 20 dB.  
The adenoid size was measured for each patient before the
operation. The lateral skull radiography was taken, and ade-
noid hypertrophy was measured using the adenoidal nasopha-
ryngeal ratio (6). The measured ratio was categorized in this
way: under 0.25 as grade 0, 0.26 to 0.5 as grade 1, 0.51 to 0.75
as grade 2 and over 0.75 as grade 3. The tympanic membrane
(TM) was evaluated before the operation using a 0 endoscope.
The TM was classified as retraction, bulging, hyperemia and
effusion. During the operation, the characteristics of middle ear
effusion were recorded and classified as serous, mucoid, pus-
like or glue. The characteristics of the effusion were determined
by the operator. The amount of effusion after myringotomy
during VT insertion was measured and this was recorded as
absent or scanty vs. profuse. The extrusion time was compared
between the groups by using one-way analysis of variance
(ANOVA) according to the adenoid size, the TM status, the
characteristics of middle ear effusion and the amount of effu-
sion. Data analysis and statistical tests were performed using
the SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). An indepen-
dent t-test, ANOVA, multivariate analysis and multiple regres-
sion analysis were used for statistical analysis. Statistical signifi-
cance was accepted at the level of P<0.05. The statistical analy-
ses were performed by an independent statistician in the
Medical Research Collaborating Center.   
RESULTS
The total number of VT insertions was 177 and this number
included 30 ears with multiple insertions. The median age of
the patients at the time of VT insertion was 4.72 yr (range, 1.2
Fig. 1. Extrusion time of the ventilation tube. Frequency histogram of the ventilation tube extrusion time. The ventilation tube’s mean extrusion time was
9.1 months (254 days).
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Monthsto 11.0 yr). The mean extrusion time was 254 days (range, 11
to 809 days) (Fig. 1). The statistical analysis for the various fac-
tors and extrusion times is shown in Table 1. When a P-value
of 0.2 was set as the criterion, age (< 7 yr vs. ≥7 yr), gender
(male vs. female), a previous history of VT insertion (none vs.
more than once) and the effusion characteristics (serous, mucoid,
pus, glue) were chosen as factors to evaluate on multivariate
analysis. Multiple regression analysis was carried out since there
was no relationship between the factors according to multi-
collinearity. The change of the extrusion time was statistically
significantly explained by a suitable regression line (P=0.0001).
Demographics
The extrusion time of the VT had a tendency to be longer for
the younger patients (age, <7 yr old; mean extrusion time, 263
days) than that for the older patients (age, ≥7 yr old; mean extru-
sion time, 177 days) on univariate analysis, but this was not signif-
icantly different (P=0.180, multiple regression). The extrusion
time was not significantly different between the males and females
(243 days vs. 281 days, respectively; P=0.121, multiple regression
analysis). 
Previous history of VT insertion
The patients with no history of VT insertion had a longer extru-
sion time than that of the patients who had undergone previous
VT insertion (mean extrusion time, 279 days vs. 203 days, respec-
tively), and this difference was statistically significant (P=0.013,
multiple regression analysis). There was a decrease of the extru-
sion time of 59.62 days for the patients with a previous history of
VT insertion as compared with that of the patients who under-
went VT insertion for the first time.
Adenoid hypertrophy
The extrusion time tended to increase with an increase of ade-
noid hypertrophy (grade 0, 202 days; grade 1, 231 days; grade
2, 266 days; grade 3, 307 days). However, there was no statisti-
cal significance (P=0.362). There was no difference in the extru-
sion time between the patients who had VT insertion accompa-
nied by adenoidectomy (mean, 272 days) and those who had
VT insertion without adenoidectomy (mean, 252 days; P=0.516). 
Preoperative evaluation
No significant difference of the extrusion time was found among
the four groups based on the TM status: retraction (259 days),
bulging (231 days), hyperemia (171 days) and effusion (259 days)
(P=0.556). No difference of the extrusion time was found between
the class B impedance group (254 days) and the class C imped-
ance group (263 days, P=0.73). There was no difference
between the two air bone gap groups: AB gap ≤20 dB (185
days) and AB gap>20 dB (162 days) (P=0.692). 
Evaluation during operation
The patients with serous effusion had the shortest extrusion
time (mean, 190 days), compared to those with glue-like (273
days), mucoid (283 days) and pus-like (295 days) effusions
(Table 2). When we set the dummy variables to the glue-like
group, there was a significant difference between the patients
with serous and glue-like (P<0.001) effusions, and there was no
differences between the patients with glue-like and pus (P=0.429)
effusions, and those with glue-like and mucoid effusion (P=0.987).
The serous and pus groups also showed a significant difference
for the extrusion time (P=0.124). The mucoid group did not
show a significant difference from the serous group for the extru-
sion time (P=0.0675). This showed that the serous group was dif-
ferent from the other groups on multiple regression analysis.
There was no significant relationship between the extrusion
time and the amount of effusion (265 days [absent or scanty]
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Factors Ear (n) 
Extrusion time of VT (days)
P-value
Mean SD
Table 1. Statistical analysis of the various factors and the ventilation
extrusion time
Statistical analysis; independent t-test, one way analysis of variances.
*Multiple regression analysis; 
� P<0.05.
VT: ventilation tube; TM: tympanic membrane. 
Age*
<7 yr 159 262.9 144.9
≥7 yr 18 177.5 138.2 0.179
Gender*
Male 123 242.7 141.3
Female 54 280.5 155.0 0.121
Previous history of VT insertion*
None 120 278.6 141.3
≥1 57 203.0 144.0 0.013
�
Adenoid size
0 11 202.8 179.2
1 32 231.8 96.7
2 32 265.6 135.5
3 5 306.7 207.4 0.362
Accompanied adenoidectomy
No 148 252.1 148.2
Yes 28 272.6 145.3 0.516
Tympanometry
B 96 254.1 147.3
C 44 263.2 139.9 0.73
Effusion amount
Absent or scanty  53 265.7 159.5
Profuse 68 269.9 144.1 0.880
TM Findings
Retraction 56 259.2 146.8
Bulging 24 230.5 119.0
Hyperemia 4 171.2 21.8
Effusion 52 259.1 152.0 0.556
Air bone gap on audiometry
≤20 dB 8 184.9 84.9
>20 dB 7 161.6 135.3 0.692vs. 267 days [profuse], P=0.880).
DISCUSSION
There have been several studies that have evaluated the factors
affecting the VT extrusion time, but there is no consensus and
the results have been diverse. While our primary goal was to
determine the effect of the characteristics of middle ear effusion
on the VT extrusion time, this study provided an excellent
opportunity to monitor other parameters that might also influ-
ence the extrusion time. 
Age
Gibb and Mackenzie (7) reported that age had no significant
effect on extrusion. In contrast, Leopold and McCabe (2) reported
a negative correlation between the longevity of tube functioning
and an age ≥10 yr. Various factors associated with age have
been found to be correlated with OME. The prevalence of OME
and Eustachian tube (ET) growth are related to age. The inci-
dence of OME recurrence decreases when the patient’s age at
VT removal or extrusion is 7-8 yr (8). Bylander et al. (9) and
Tos et al. (10) reported an improvement of the ET function as
well as a drastic fall in the prevalence of secretory otitis to 7%
at the age of 6-7. We expected that the extrusion time of VT
may be related to the link between age and the growth and
function of the ET, but our study showed no difference between
patients under and over the age of 7. 
Previous history of VT insertion
Leopold and McCabe (2) reported that the VT remained in the
TM of the patients with no history of previous VT insertion sig-
nificantly longer than that in the patients who were previously
intubated. Our study had the same findings, that is, there was a
longer extrusion time for the VT insertion patients with no pre-
vious history of VT insertion (279 days) than that of the
patients who had undergone previous intubation (203 days).
Effusion characteristics and the amount of effusion
The types of middle ear effusion vary from serous fluid to thick
glue-like secretions. Carrie et al. reported that the viscosity of
mucoid effusions was significantly greater than the viscosity of
serous effusions, and the only constituent in effusions that deter-
mines the viscosity is mucin, not protein or lipid. They conclud-
ed that thick (mucoid) and thin (serous) middle ear effusions
can be classified on the basis of visible inspection and the flow
properties (11). 
Allen et al. (12) reported that the children at high risk for
developing postoperative complications after VT insertion were
more likely to have mucopus in the ear at the time of surgery.
Ahn et al. (13) reported that the percentage of glue-like effu-
sion was decreased with repeated VT insertion procedures. A
previous study suggested that different effusions with various
levels of enzymes and proteins were correlated with recurrent
cases of OME (14). In contrast, Gibb and Mackenzie (7) and
Maw et al. (15) reported that there was no significant difference
of the VT extrusion rate when the middle ear fluid was divided
into liquid, glue and very thick glue. 
The role of cytokines, which is a group of glycoproteins that
participates in the modulation of inflammatory and immune
reactions in many diseases, has recently been emphasized in
OME (16). Earlier studies have documented the presence of
several cytokines in the middle ear effusions of humans and
experimental animals, including tumor necrosis factor (TNF)a,
interleukin (IL) 1b, IL-2, IL-6, and IL-8, interferon (IFN)-γ and
TNF soluble receptor (17-19). Kariya et al. (20) compared the
cytokine expression according to the type of effusion. The con-
centration and incidence rate of IL-10 in mucoid OME were sig-
nificantly higher than those in serous OME. However, other
cytokines (IL-2, IL-4, IL-5, IL-12, and IFN-γ ) were not signifi-
cantly different between the two groups. Hotomi et al. (18) also
reported that the mean level of IL-8 in serous effusion was lower
than that in the other two types of MEE (mucoserous and
mucoid) (18). TNF-a may be associated with histopathological
changes in the middle ear mucosa and the production of mucoid
OME in patients with persistent chronic OME. Maeda et al. inoc-
ulated TNF-a and endotoxin into the middle ear cavity of rats,
followed by ET obstruction, and this resulted in mucous cell
metaplasia-hyperplasia that was accompanied by abundant
mucin or mucin-like glycoproteins in middle ear effusions (21).
Similarly, Smimova et al. (22) reported that the mucin content
of effusions was correlated with the concentration of IL-4 and
IL-13, suggesting the involvement of IL-4 and IL-13 in the
upregulation of middle ear mucin metabolism. The IL-8 concen-
tration was positively correlated with the type of effusion and
the total number of neutrophils in OME (18).
In our study, the extrusion time in the serous effusion group
(191 days) was shorter than that in the mucoid (283 days), pus
(296 days) and glue (252 days) effusion groups. Serous effusion
has a lower viscosity as compared to that of glue, pus and mucoid
effusions. Takahashi et al. (23) suggested that viscous effusion
aggravates the ET function as a result of OME. In evaluating the
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No. Extrusion time (days) Probability > |t|
Table 2. Extrusion time according to the characteristics of the mid-
dle ear effusion and the results of multiple regression analysis
Multiple regression analysis was performed using dummy variables as the
glue group. 
*P<0.05.
Serous 48 190.5±143.3 0.0008*
Mucoid 12 283.3±58.7 0.9872
Pus 11 295.5±82.8 0.4289
Glue 99 251.8±149.2 -pathogenesis of the course of OME, Hormann concluded that
the viscosity of the effusion reflects the stage and progression of
OME (24). A serous effusion possibly suggests an early stage of
OME and the patients with a serous effusion have better ET
function; the patients with serous OME heal faster than do the
patients with OME with highly viscous effusion (which is in a
more advanced stage of the disease with a higher mucin con-
centration and cytokine interaction).
The amount of effusion during VT insertion (absent or scanty
vs. profuse) had no significant effect on the extrusion time
(P=0.880). Jeon et al. (25) reported that blockage of VT in the
immediate postoperative period had no significant effect on the
amount of middle ear effusion that was graded as dry, small,
moderate and large.
Adenoid hypertrophy and associated adenoidectomy
Adenoid hypertrophy and chronic or recurrent adenoiditis have
been postulated as contributing factors in the development of
recurrent AOM and chronic OME (26). Yet in relation to the
removal of the adenoid, Iwaki et al. (8) reported that adenoidec-
tomy did not influence the recurrence rate of OME. Similarly,
Mackenzie (5) and Gibb and Mackenzie (7) reported that
simultaneous operative procedures, including adenoidectomy,
had no significant effect on the extrusion rate of VT. Our study
had corresponding results with no difference of the extrusion time
between the patients who had an accompanying adenoidecto-
my (252 days) and those who did not (272 days, P=0.516), and
there was no difference according to the adenoid size.
Audiometry and tympanometry 
Sichel et al. (27) analyzed the viscosity of ear effusion and tym-
panometry, along with the AB gap on audiometry. No correla-
tion was found between the viscosity of the middle ear fluid
and the three parameters of tympanometry as well as between
the viscosity and the AB gap. In our study, there was no signifi-
cant relationship between the preoperative tympanometry B
and C groups (P=0.73). Also, no difference was found between
the patients in the AB gap 20 dB or smaller group and the group
of patients with an AB gap larger than 20 dB (P=0.692).
TM findings
Mackenzie (5) reported that the quality of the TM did not affect
the extrusion rate. Gibb and Mackenzie (7) analyzed the TM as
normal, thin scarred, tympanosclerosis, thick and gross retrac-
tion; they concluded that the TM status did not affect the extru-
sion rate. In our study, the TMs were grouped as retraction,
bulging, hyperemia and effusion, and there was no significant
relationship (P=0.556).
In our study, gender was not significantly related to the extru-
sion time (P=0.114), which corresponds to the previous reports
(5, 7). Bleeding during VT insertion did not have a significant
relationship with the extrusion time (P=0.143), which is also
consistent with previous reports (5, 7, 25).
The design of the VT has been reported to be a significant deter-
minant of the extrusion rate without any debate (2, 7, 28, 29). Our
study was confined to the Paparella type I VT (Medtronic Xomed,
Jacksonville, FL, USA). Operator experience and general anes-
thesia are factors that have been reported to prolong the VT
extrusion time (2, 5). There is also controversy about the effect of
the quadrant of the TM where the VT is inserted on the extru-
sion time. Shah (3) reported that inserting the VT in the anteri-
or segment of the TM prolongs the VT functioning time.
However, Mackenzie (5) and Hern and Jonathan (28) reported
that the portion of the TM portion where the TV is incised had
no significant effect. Otic drop use, left ear surgery, repeated
otorrhea episode, a loose VT at insertion and the presence of
concurrent infection have been reported to shorten the extru-
sion time (4, 5, 24, 25, 28).
The mean extrusion time of the VT was 254 days in our study.
Two factors remained significant predictors of the extrusion
time: the characteristics of the middle ear effusion and a history
of previous VT insertion. No other factor appeared to influence
the extrusion time. Additional prospective randomized studies
with a large number of patients are needed to validate this find-
ing. The nature of middle ear effusion can provide a clinical
clue to predict the extrusion time of VT. More caution must be
given to older patients and those with a previous history of VT
insertion.  
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